Dabrafenib plus trametinib versus nivolumab for advanced melanoma

Autor: Daniela Lahoz, Felipe Reyes, Camila Quirland

Publikováno v: Medwave, Vol 23, Iss 01, Pp e2666-e2666 (2023)

Introduction The incidence of cutaneous melanoma has increased worldwide over the years, and an incidence of 3 cases per 100,000 men and women is estimated in Chile. Though most of the patients are diagnosed at an early stage of the disease and have

Externí odkaz: https://doaj.org/article/d90180f81c8f44c4b96081bf75c3ddc4

Effect of intraoperative radiotherapy for patients with low-risk early-stage breast cancer

Autor: Pedro Ferrer, Luz María González, Diego Carreño, Camila Quirland, Badir Chahuán

Publikováno v: International Journal of Radiology and Radiation Oncology. :001-005

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c5bdcba2e78e82029992a1c86826681f
https://doi.org/10.17352/ijrro.000043

Determinants of Cost-Effectiveness results of Biological Therapies for Severe Asthma: a systematic methodological assessment.

Autor: Torre-Pérez L; Methodology of Biomedical Research and Public Health PhD Program, Universitat Autónoma de Barcelona, Spain; Institut de Recerca Sant Pau (IR SANT PAU), Sant Quintí 77-79, 08041, Barcelona, Spain; Centro Cochrane Iberoamericano, Sant Antoni Maria Claret, 167, 08025 Barcelona, Spain. Electronic address: lr.delatorre.prz@gmail.com., Santero M; Methodology of Biomedical Research and Public Health PhD Program, Universitat Autónoma de Barcelona, Spain; Institut de Recerca Sant Pau (IR SANT PAU), Sant Quintí 77-79, 08041, Barcelona, Spain; Centro Cochrane Iberoamericano, Sant Antoni Maria Claret, 167, 08025 Barcelona, Spain., Nieto-Gutierrez W; Methodology of Biomedical Research and Public Health PhD Program, Universitat Autónoma de Barcelona, Spain; Institut de Recerca Sant Pau (IR SANT PAU), Sant Quintí 77-79, 08041, Barcelona, Spain; Centro Cochrane Iberoamericano, Sant Antoni Maria Claret, 167, 08025 Barcelona, Spain; Universidad San Ignacio de Loyola, Unidad de Investigación para la Generación y Síntesis de Evidencias en Salud, Lima, Perú., Giesen C; Centro de Salud Internacional Madrid Salud, Ayuntamiento de Madrid, Madrid, Spain., Nardin A; Department of Diagnostics and Public Health, University of Verona, Via San Francesco 22 - 37129 Verona, IT; Ecohealth Unit, Environment and Health Department, Italian National Institute of Health, Viale Regina Elena 299 - 00161, Rome, IT., Cosma C; School of Specialization in Hygiene and Preventive Medicine, Department of Health Sciences, University of Florence, 50134 Florence, Italy., Pires PS; Hospital S. Teotónio, Centro Hospitalar Tondela-Viseu, Viseu, Portugal., Guida A; School of Specialization in Hygiene and Preventive Medicine, Department of Health Sciences, University of Florence, 50134 Florence, Italy., Simonini M; Department of Diagnostics and Public Health, University of Verona, Via San Francesco 22 - 37129 Verona, IT., Lazo CQ; Methodology of Biomedical Research and Public Health PhD Program, Universitat Autónoma de Barcelona, Spain., Xie F; Department of Health Research Methods, Evidence, and Impact, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada; Centre for Health Economics and Policy Analysis (CHEPA), Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada., Alonso-Coello P; Institut de Recerca Sant Pau (IR SANT PAU), Sant Quintí 77-79, 08041, Barcelona, Spain; Centro Cochrane Iberoamericano, Sant Antoni Maria Claret, 167, 08025 Barcelona, Spain; CIBER de Epidemiología y Salud Pública, Instituto de Salud Carlos III (CIBERESP), Spain.

Publikováno v: Journal of clinical epidemiology [J Clin Epidemiol] 2024 Dec 03, pp. 111621. Date of Electronic Publication: 2024 Dec 03.